Inspections, Compliance, Enforcement, and Criminal Investigations
Grand BK Corp. - Close Out Letter 3/23/12
| Public Health Service Food and Drug Administration |
New York District |
March 23, 2012
Brian J. Kwon, President
Grand BK Corp.
47-08 Grand Avenue
Maspeth, New York 11378-3007
Dear Mr. Kwon:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter NYK -2011-38 dated September 30, 2011. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Dean Rugnetta
Compliance Officer
New York District





Department of Health and Human Services

